DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 4Alfred E Tiefenbacher GmbH
03 2Accord healthcare
04 2Actavis Inc
05 8Alphapharm PTY Ltd
06 4Apotex Inc
07 8Arrotex Pharmaceuticals
08 2Aurobindo Pharma Limited
09 10Cipla
10 2Cipla Medpro South Africa
11 2Deva Holding AS
12 2Devatis AG
13 2ENDO OPERATIONS
14 14GSK
15 2Gilead Sciences
16 2Indoco Remedies Limited
17 2JAMP PHARMA
18 2Medac
19 2Mepha Pharma
20 2OrPha Swiss
21 2Sandoz B2B
22 8Seekwell
23 2Sigmapharm Laboratories, LLC
24 2Sun Pharmaceutical Industries Limited
25 2Teva Pharmaceutical Industries
26 4Viatris
27 2Zentiva
28 2Zydus Pharmaceuticals
01 1Ambrisentan 10Mg 30 Joined' Oral Use
02 1Ambrisentan 5Mg 30 Joined' Oral Use
03 2Antic-calc Tablet, Film Coated
04 4FCT
05 2FILMDRAGERAD TABLETT
06 4Film Coated Tablet
07 2Film Coated Tablet - Oral
08 2Film-Coated Tablet For Oral Use,
09 10Film-Coated Tablets
10 4Filmtabl
11 2Filmtable
12 2Lactab
13 8TABLET
14 20TABLET;ORAL
15 6Tablet
16 32tablet
01 2DISCN
02 6Generic
03 2Originator
04 8Prescription
05 18RX
06 4Status- Under Registration
07 62Blank
01 18AMBRISENTAN
02 2AMBRISENTAN ACCORD
03 2AMBRISENTAN DR. REDDY'S
04 2AMBRISENTAN MEDAC
05 2AMBRISENTAN MYLAN
06 2AMBRISENTAN TEVA
07 2AMBRISENTAN ZENTIVA ITALY
08 2APO-AMBRISENTAN
09 2Ambrisentan Devatis
10 2Ambrisentan OrPha
11 8Ambrisentan Viatris
12 2Ambrisentan-Mepha
13 8Cipla Ambrisentan
14 2JAMP AMBRISENTAN
15 2LETAIRIS
16 8PULMORIS
17 2SANDOZ AMBRISENTAN TABLETS
18 4VOLIBRIS
19 16Volibris
20 1Volibris 10 mg
21 1Volibris 5 mg
22 1Volmaro 10
23 1Volmaro 5
24 10Blank
01 32Australia
02 8Canada
03 4Germany
04 4India
05 16Italy
06 2Norway
07 4South Africa
08 2Sweden
09 8Switzerland
10 2Turkey
11 20USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN DR. REDDY'S
Dosage Form : Film-Coated Tablets
Dosage Strength : 10 mg
Packaging : 30 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN DR. REDDY'S
Dosage Form : Film-Coated Tablets
Dosage Strength : 5 mg
Packaging : 30 UNITS 5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2022-05-19
Application Number : 210701
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2022-05-19
Application Number : 210701
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2022-07-21
Application Number : 216531
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2022-07-21
Application Number : 216531
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 210715
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-04-26
Application Number : 210715
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LETAIRIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2007-06-15
Application Number : 22081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LETAIRIS
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2007-06-15
Application Number : 22081
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Volibris
Dosage Form : FILMDRAGERAD TABLETT
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Volibris
Dosage Form : FILMDRAGERAD TABLETT
Dosage Strength : 5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-04-10
Application Number : 208354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-04-10
Application Number : 208354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 210784
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 210784
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208441
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208441
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 210058
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 210058
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-04-10
Application Number : 209509
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-04-10
Application Number : 209509
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
